Xinafoate salt of a substituted 5-oxazol-2-yl-quinoline...

Details Xinafoate salt of a substituted 5-oxazol-2-yl-quinoline... Xinafoate salt of a substituted 5-oxazol-2-yl-quinoline...

2011-04-05

2011-04-05

Seaman, D. Margaret (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S159000, C546S163000

Reexamination Certificate

active

07919505

ABSTRACT:
The present invention relates to the compound of the formulaTo methods of treating upper and lower obstructive airway diseases using said compound, to formulations comprising it, and to polymorphs and processes of synthesis of the polymorphic forms.

REFERENCES:
patent: 5270324 (1993-12-01), Zamboni
patent: 5296495 (1994-03-01), Matsuo
patent: 5352707 (1994-10-01), Pompni
patent: 5472964 (1995-12-01), Young
patent: 5804588 (1998-09-01), Dyke
patent: 5834485 (1998-11-01), Dyke
patent: 6069151 (2000-05-01), Dyke
patent: 7511062 (2009-03-01), Kuang et al.
patent: 2005/0017134 (2005-01-01), Hooper
patent: 2005/116009 (2005-12-01), None
patent: WO 2005/116009 (2005-12-01), None
patent: WO 2006/105401 (2006-10-01), None
West al., “Identification of Two H3-Histamine Receptor Subtypes”, Molecular Pharmacology, 38: 610-613 (1990).
PCT International Search Report dated Jan. 21, 2008 for PCT Application No. PCT/US2007/015715.

Affiliated with

Also associated with

Rating

Xinafoate salt of a substituted 5-oxazol-2-yl-quinoline... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Xinafoate salt of a substituted 5-oxazol-2-yl-quinoline..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Xinafoate salt of a substituted 5-oxazol-2-yl-quinoline... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2740624